Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
11/20/2020
11/23/2020
11/24/2020
11/25/2020
11/26/2020
Date
118
117.31
117.23
114
113.33
Last
5426179
5519113
3611951
3978699
4387126
Volume
+2.25% -0.58% -0.07% -2.76% -0.59% Change
Sales 2020
3 250 M 494 M 494 M
Net income 2020
1 538 M 234 M 234 M
Net cash position 2020
12 084 M 1 838 M 1 838 M
P/E ratio 2020
61,9x
Yield 2020
0,35%
Sales 2021
4 287 M 652 M 652 M
Net income 2021
1 469 M 223 M 223 M
Net cash position 2021
12 737 M 1 937 M 1 937 M
P/E ratio 2021
64,1x
Yield 2021
0,36%
Capitalization
99 214 M 15 088 M 15 092 M
EV / Sales 2020
26,8x
EV / Sales 2021
20,2x
Nbr of Employees
-
Free-Float
100,0%
Hangzhou Tigermed Consulting Co, Ltd. specialises in providing professional services to pharmaceutical and biotech companies. The group supports its clients in all processes of clinical development and product commercialization. Net sales break down by activity as follows:
- provision of clinical trial services and related technological services (51.9%);
- provision of clinical research consulting services...
Notations Surperformance© of Hangzhou Tigermed Consulting Co.,Ltd
Trading Rating : Investor Rating :
All news about HANGZHOU TIGERMED CONSULTING CO.,LTD
News in other languages on HANGZHOU TIGERMED CONSULTING CO.,LTD
Chart HANGZHOU TIGERMED CONSULTING CO.,LTD
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends HANGZHOU TIGERMED CONSULTING CO.,LTD
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
15
Average target price
124,87 CNY
Last Close Price
113,33 CNY
Spread / Highest target
29,2%
Spread / Average Target
10,2%
Spread / Lowest Target
-26,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
